Filtered By:
Infectious Disease: Adenoviruses
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Neuroscience is the Next Oncology
by Michael D. Ehlers, MD, PhD
Dr. Ehlers is with Biogen in Cambridge, Massachusetts.
Innov Clin Neurosci. 2018;15(3–4):15–16
Funding: No funding was received for the preparation of this article.
Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts.
Prominent and expensive failures in Alzheimer’s disease therapies have led to a contagious belief system in some parts of the biopharma industry that neuroscience is just too hard, too risky, and too uncertain. But, might this belief system itself be a residual bias of the past? Close inspection reveals all the signs of a coming...
Source: Innovations in Clinical Neuroscience - April 1, 2018 Category: Neuroscience Authors: ICNS Online Editor Tags: Commentary Current Issue Source Type: research
